Panome Bio, a St Louis-based metabolomics and proteomics providers firm that gives biopharma innovators entry into the biomolecules closest to phenotype and performance, closed a development financing spherical of undisclosed quantity.
The spherical was led by Telegraph Hill Companions, with participation from BioGenerator Ventures. Deval Lashkari, Rob Capone, and Alex Herzick from Telegraph Hill Companions will be a part of Panome Bio’s board of administrators. Edward Weinstein, Chief Govt Officer and Co-founder, and David Smoller, Co-founder, will even maintain seats on the Panome Bio Board.
The financing will likely be used to develop new applied sciences and capabilities, increase laboratory services, and develop the Panome Bio workforce to service the growing curiosity in metabolomics and proteomics knowledge.
Launched across the Subsequent-Technology Metabolomics™ know-how developed by Chief Scientific Officer, Dr. Gary Patti, and led by CEO Edward Weinstein, Panome has developed a platform that makes use of superior liquid chromatography – mass spectrometry assays and proprietary bioinformatic instruments to realize actionable insights to metabolic pathways concerned in most cancers, growing old, drug metabolism, and different areas. The corporate works with pharmaceutical and biotech corporations and pairs Subsequent-Technology Metabolomics with high-throughput proteomics to additional advance analysis in biomarker discovery and drug growth.
Dr. Patti can be the Michael and Tana Powell Professor at Washington College in Saint Louiswhere his lab is a pacesetter within the area of metabolomics. He’s identified for a lot of key developments together with creating gold-standard metabolomics evaluation software program and workflow optimization that permit for world metabolomics screens.
